Search
for
Sort by
Research 211–240 of 1000+
- Effects of Topical application of Astragalus membranaceus in Spontaneous Alopecia Mice Model
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Lichen Planopilaris
- Keratin 17 modulates hair follicle cycling in a TN<i>Fα</i>-dependent fashion
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity
- 698 Effect of lithocholic acid as a ligand of vitamin D receptor on hair growth in alopecia
- Wound management in hidradenitis suppurativa
- Wnt/β-catenin and ERK pathway activation: The possible mechanism of various light-emitting diode light regulates the proliferation of human outer root sheath cells
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Autoimmunity and autoimmune co-morbidities in psoriasis
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Efficacy of tofacitinib in pediatric alopecia universalis
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- General Dermatology
- Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma
- Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF
- What causes hidradenitis suppurativa ?—15 years after